Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron plus dexamethasone with or without dexamethasone continuation on days 2 and 3 for prevention of chemotherapy-induced nausea and vomiting
2006-000644-13Phase 3Completed
- Sponsor
- ITMO University
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of palonosetron and dexamethasone in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by ITMO University. Primary endpoint: Overall complete response during the first 5 days after chemotherapy cycle 1. Started Oct 2006; status: completed.
02
Drugs
palonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2006-000644-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000644-13.